Motor Neurone Disease Trial, Recruiting NCT06595212 Sponsor: Azienda Ospedaliero-Universitaria di Modena Condition: Motor Neurone Disease
Back to Motor Neurone Disease

Motor Neurone Disease Trial, Recruiting

NCT06595212
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are over 18 years old
  • Twin pairs (either identical or non-identical twins) where both twins are willing to take part and able to give their consent to join the study
  • Twin pairs where at least one twin has been diagnosed with ALS (a disease affecting the nerves that control movement) or FTD (a type of dementia affecting behaviour and language), based on specific medical diagnostic criteria
  • People who are able and willing to follow all the study procedures as described in the protocol
  • People who are able to understand the study and give their own informed consent at the first screening visit, before any study procedures begin

Who may not be able to join:

  • Twin pairs where either twin is unwilling to complete the required assessments, at minimum at the first baseline visit
  • Twin pairs where either twin is unwilling to donate biological samples collected from the body (such as blood), noting that spinal fluid collection via lumbar puncture is not required
  • Women who are currently pregnant or breastfeeding

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 26 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 0593961640

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Azienda Ospedaliero-Universitaria di Modena
Registry
ClinicalTrials.gov
Start date
29 January 2024
Est. completion
29 January 2026

Where this trial is recruiting

🇮🇹 Italy

Primary endpoints

Environmental/genetic risk/protective factors involved in driving discordance in monozygotic (MZ) twins

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 26 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov